Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Cannabis

Cannabis

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Cannabis
  • Earnings
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

Mydecine’s Q3 Financials & Update, Sustained Target On Smoking Cessation For Next 12 Months

By Lara Goldstein
Today, 12:25 PM
Mydecine Innovations Group (OTC: MYCOF), the psychedelics biotech company headquartered in Denver, Colorado with international offices in the Netherlands, reported its financial results and business highlights for the three and nine months ended September 30, 2022.

MYCOF

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Rubicon Organics Hits Record Revenue Of $7.9M In Q3, What About Adjusted EBITDA?

By Vuk Zdinjak
Today, 11:51 AM
Rubicon Organics Inc. (OTCQX: ROMJF) (TSXV:ROMJ) released its financial results for the third quarter ended September 30, 2022, revealing record net revenue of CA$10.5 million ($7.9 million), a 49% increase compared to CA$7 million in Q3 2021, and a 19% incr

ROMJF

Read More
4 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Psychedelics
  • Small Cap

Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup

By Lara Goldstein
Today, 11:46 AM
Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics

ATAI

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Charlotte’s Web Stock Slightly Up On Secured $56.8M Investment From BAT

By Vuk Zdinjak
Today, 11:04 AM
Charlotte's Web Holdings, Inc. (OTCQX: CWBHF) (TSX:CWEB) announced a $56.8 million investment from a subsidiary of BAT (NYSE: BTI) (LSE:BATS), which provides the company with incremental capital to fund growth initiati

BTI

Read More
1 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Cannabis Tech & Marketing Platform Leafbuyer Q3 Revenue Grows 33% YoY

By Nina Zdinjak
Today, 10:37 AM
Cannabis technology and marketing platform Leafbuyer Technologies, Inc. (OTCQB: LBUY) reported Tuesday financial results for the third quarter ended Sep. 30 with revenue of $1.13 million, up by 32.5% from $851,693 in the same period year ago.

LBUY

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News

Israeli Cannabis Producer Touts Record Q3 Revenue, Gross Profit Increase

By Jelena Martinovic
Today, 10:20 AM
InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR), which is doing business as Canndoc, announced on Tuesday its financial and operating results for the third quarter ended September 30, 2022.

INCR

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Cresco Labs Q3 Revenue Drops Slightly YoY, Cuts Net Loss

By Vuk Zdinjak
Today, 9:59 AM
Cresco Labs Inc. (CSE:CL) (OTCQX: CRLBF) (FSE:6CQ) Q3 2022 revenue was $210 million, down 2% year-over-year. Q3 2022 Financial Highlights

CRLBF

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Unrivaled Brands Revenue Declines 46% YoY To $10.76M

By Vuk Zdinjak
Today, 7:55 AM
Unrivaled Brands, Inc. (OTCQX: UNRV) Q3 2022 revenue was $10.76 million, a decrease of 46% compared to revenue of $20.05 million in the Q3 2021. Q3 2022 Highlights

UNRV

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks
  • Tech

Cannabis SaaS Provider Springbig Reports 3Q 2022 Financial Results: Total Revenue Up 22% YoY

By Nicolas Jose Rodriguez
Yesterday, 8:27 PM
SpringBig Holdings, Inc.

SBIG

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

The Parent Company Q3 Revenue Drops 28% Sequentially, CEO Says New Products Coming Soon

By Joana Scopel
Yesterday, 8:22 PM
The Parent Company (NEO: GRAM.U) (OTCQX: GRAMF) announced its financial results on Monday for the quarter ended September 30, 2022 ("Q3 2022"). “All amounts are expressed in U.S. dollars,” reads a press release.

GRAMF

Posts pagination

Previous 1 … 354 355 356 … 449 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service